Long Term Physical Activity for Hemodialysis Patients
Açar sözlər
Mücərrəd
Təsvir
General Context Chronic Kidney Patients (CKD) live a sedentary life. Sedentarity and Sarcopenia worsen during the evolution of CKD with numerous cardiovascular diseases, infectious and other comorbidities. Inactivity may activate and amplify the inflammatory process, hypercoagulability, malnutrition, invoking a vicious circle of further inactivity and deconditioning.
These populations have a very low physical activity profile due to important tiredness, perturbed general condition and bad adaptation in effort. The patients with cardiovascular problems have additional limitations due to breathlessness associated with congestive cardiac failure and intermittent claudication due to peripheral arteriopathy. At the dialysis stages the tiredness is accentuated after the hemodialysis sessions. The days off dialysis are rarely used for practicing a physical activity.
The deconditioning along with the reduction of the physical activity are leading to a de-socializing progressing in the course of the chronic renal failure. In that way the patient feels more and more isolated with a serious eventual impact on the nutrition status and his quality of life.
Regular physical activity in this population of patients is exerting beneficial effects on insulin resistance, inflammation, dialysis efficiency, nutrition and arterial pressure. It may also reduce the intradialytic hypotensive episodes and improve quality of life, without side effects.
The objective of this study is to investigate an improvement of the physical functioning associated with a reprogramming of the autonomous nervous system, a reduction of the pro-inflammatory factors with a reduction of the insulin resistance (reduction of the metabolic syndrome), along with improvements on the immune system functioning for hemodialysis patients participating on a one year intradialytic physical activity program.
Principal objective :
The principal aim of the present study is to show the efficacy of intradialytic physical activity on functional capacity with the sit-to-stand test in 60 seconds (STS60) and the time to perform 5 complete sit-to-stand movements (STS5) along with a 6 minutes' walk test (6MWT).
Secondary objectives :
The secondary objectives are the amelioration of parameters associated with cardiovascular, sympathetic or autonomous nervous system, immune, nutritional, metabolic and inflammatory outcomes among with quality of life.
This is a multicenter, controlled randomized trial
Study description:
Inclusion of patients willing to participate in the study, and consequently their randomization in 2 groups.
The intervention group will benefit from a supervised physical activity during the dialysis session and the other group will carry on with his usual physical activities and have the same tests before and after the trial without undergoing a supervised intradialytic physical activity program
Primary judgment criteria :
The principal criteria will be the effect of an aerobic training program with a warming up phase, followed by 30 minutes of intradialytic cycling on 55% of the VO2max, 3 times a week.
The primary judgement criteria will be the improvement of the Sit-to-stand test in 60 seconds (STS60) and the time to complete 5 sit-to stand movements (STS5) as well as the 6 minutes' walk test (6MWT) from T0 (before the training program) to T12 (12 months after the start of the training period)
Secondary criteria:
- Quality of life parameters evaluated from the questionaries SF36 (The Short Form (36) Health Survey), Borg scale, EVA.
- Physical activity levels: IPAQ (international physical activity questionary).
- Body composition (Fat mass, lean mass, bone mineral density, estimation of the muscular mass) with DEXA (dual-energy x-ray absorptiometry).
- Cardiovascular parameters : Cardiac echography, doppler of the carotid arteries and the lower extremity arteries, 24h cardiac rhythm exploration
- Immune parameters: leucocyte subpopulation functioning
- Nutritional and metabolic parameters: weight, BMI, albumin, pre-albumin, pre- and post-dialytic serum urea and creatinine levels, nPCR (normalised Protein catabolic Rate).
- Inflammatory parameters :(Interleucin) IL1 bêta, IL6, IL8, IL-10, TNF alpha (Tumor necrosis factor alpha), CRP (C reactive protein)
- Dialysis parameters : Kt/v, anemia control : Hemoglobin (Hb), MCV (mean corpuscular volume), ferritin, erythropoetin dosage (EPO).
- Number, etiology and duration of hospitalisations
- Survival in 1 year
Number of participants : 100, ie 50 per group
Layout of the study :
Inclusion of the patient, evaluations at the start of the study protocol, at 6 months and at the end -12 months (M0, M6, M12).
Benefits and risks of this study :
Improvement of functional aerobic capacity, inflammatory status and quality of life. Improvements on the state of pain, autonomy, augmentation of the lean mass with conservation of the muscular mass for the lower extremities and reduction of the total fat mass are expected as well as improvement of the nutritional status, dialysis parameters, anemia control.
The risks are of cardiovascular origin: a possible decompensation of coronary artery disease, peripheral artery disease, taking into consideration that all patients benefit from echo doppler arterial control before the start of the study.
Regular Perdialytic Activity during Dialysis is practiced in AURA Auvergne (Association pour l'Utilisation du Rein Artificiel Santé) since 2 years; there has been no secondary vascular problem associated with the supervised physical activity. Nevertheless, rare tendon problems or articular and muscular pains could be possible on the course of the study
Tarixlər
Son Doğrulandı: | 07/31/2016 |
İlk təqdim: | 07/13/2016 |
Təxmini qeydiyyat təqdim edildi: | 08/03/2016 |
İlk Göndərmə: | 08/08/2016 |
Son Yeniləmə Göndərildi: | 08/03/2016 |
Son Yeniləmə Göndərildi: | 08/08/2016 |
Həqiqi Təhsilin Başlama Tarixi: | 08/31/2016 |
Təxmini İlkin Tamamlanma Tarixi: | 08/31/2018 |
Təxmini İşin Tamamlanma Tarixi: | 04/30/2019 |
Vəziyyət və ya xəstəlik
Müdaxilə / müalicə
Behavioral: Exercisers
Behavioral: Non Exercisers
Faza
Qol Qrupları
Qol | Müdaxilə / müalicə |
---|---|
Active Comparator: Exercisers Intradialytic exercise on stationary bicycles | Behavioral: Exercisers Patients are exercising for 30-60 min during dialysis on an Rated Perceived Exertion (RPE) Scale between 12 and 14 |
Placebo Comparator: Non Exercisers No intradialytic exercise | Behavioral: Non Exercisers Patients are having their usual physical activity |
Uyğunluq Kriteriyaları
Təhsil üçün uyğun yaşlar | 20 Years Üçün 20 Years |
Təhsilə Uyğun Cinslər | All |
Sağlam Könüllüləri qəbul edir | Bəli |
Kriteriyalar | Inclusion Criteria: - Consenting active hemodialysis patients since at least 6 months aged between 20 and 90 y.o. Exclusion Criteria: - Unstable angina, - severe left ventricular dysfunction, - Ejection fraction < 30%, - severe peripheral arterial disease, - lower extremity amputation, - impossibility of physical effort: pain, uncontrolled bone/muscular disease, - participation on another study. |
Nəticə
İlkin nəticə tədbirləri
1. Improvement of the distance covered after walking for 6 minutes (6 minutes walk test) [12 months]
İkincili Nəticə Tədbirləri
1. Quality of life parameters 1 [12 months]
2. Quality of life parameters 2 [12 months]
3. Quality of life parameters 3 [12 months]
4. Physical activity levels [12 months]
5. Body composition [12 months]
6. Cardiovascular parameters [12 months]
7. Immune parametres [12 months]
8. Nutritional and metabolic parameters 1 [12 months]
9. Nutritional and metabolic parameters 2 [12 months]
10. Nutritional and metabolic parameters 3 [12 months]
11. Nutritional and metabolic parameters 4 [12 months]
12. Nutritional and metabolic parameters 5 [12 months]
13. Nutritional and metabolic parameters 6 [12 months]
14. inflammatory parameters 1 [12 months]
15. inflammatory parameters 2 [12 months]
16. inflammatory parameters 3 [12 months]
17. inflammatory parameters 4 [12 months]
18. inflammatory parameters 5 [12 months]
19. inflammatory parameters 6 [12 months]
20. Dialysis parameters [12 months]
21. Anemia control 1 [12 months]
22. Anemia control 2 [12 months]
23. Anemia control 3 [12 months]
24. Anemia control 4 [12 months]
25. Number of hospitalisations [12 months]
26. Duration of hospitalisations [12 months]
27. Survival [12 months]
28. Improvement of Sit to Stand test in 60 seconds (STS60) [12 months]
29. Improvement of the time needed to perform 5 Sit to Stand cycles (STS5) [12 months]